A new formulation — a film that dissolves under the tongue — of cladribine for treating multiple sclerosis (MS) has moved closer to clinical testing, according to an update from its developer. Bionxt Solutions announced that it has completed manufacturing of a clinical-grade batch of BNT23001, its sublingual, or under-the-tongue, formulation of cladribine. The batch […]
The post Developer creates under-the-tongue cladribine for testing in MS appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com